Does REMICADE Cause Basal cell carcinoma? 34 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Basal cell carcinoma have been filed in association with REMICADE. This represents 1.1% of all adverse event reports for REMICADE.
34
Reports of Basal cell carcinoma with REMICADE
1.1%
of all REMICADE reports
1
Deaths
3
Hospitalizations
How Dangerous Is Basal cell carcinoma From REMICADE?
Of the 34 reports, 1 (2.9%) resulted in death, 3 (8.8%) required hospitalization.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REMICADE. However, 34 reports have been filed with the FAERS database.
What Other Side Effects Does REMICADE Cause?
Infusion related reaction (313)
Crohn's disease (193)
Drug ineffective (157)
Dyspnoea (141)
Exposure during pregnancy (96)
Arthralgia (95)
Nausea (85)
Pain (84)
Vomiting (81)
Malaise (80)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which REMICADE Alternatives Have Lower Basal cell carcinoma Risk?
REMICADE vs REMIFENTANIL
REMICADE vs REMIMAZOLAM
REMICADE vs REMODULIN
REMICADE vs REPAGLINIDE
REMICADE vs REPOTRECTINIB